Archean Chemical Industries' Board approved Q1 financial results. Consolidated PAT stood at ₹30.35 Cr. Key strategic moves: invested ₹170 Cr in Acume Chemicals' rights issue, and subsidiary Sicsem secured fiscal support for up to 75% capex from India Semiconductor Mission.